{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T04:18:35Z","timestamp":1741666715662,"version":"3.38.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.urology.2024.10.071","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T12:57:48Z","timestamp":1731070668000},"page":"20-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analyzing Antibiotic Usage Trends in Genitourinary Infections and Procedures: Insights From the TriNetX Database"],"prefix":"10.1016","volume":"197","author":[{"given":"Brian H.","family":"Im","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron R.","family":"Hochberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandon","family":"Havranek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Courtney E.","family":"Capella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria J.","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Analyse H.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Whitney","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mihir S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Costas D.","family":"Lallas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2024.10.071_bib1","first-page":"455","article-title":"Quinolones: a comprehensive review","volume":"65","author":"Oliphant","year":"2002","journal-title":"Am Fam Phys"},{"key":"10.1016\/j.urology.2024.10.071_bib2","first-page":"933","article-title":"Diagnosis and management of acute pyelonephritis in adults","volume":"71","author":"Ramakrishnan","year":"2005","journal-title":"Am Fam Physician"},{"key":"10.1016\/j.urology.2024.10.071_bib3","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0025-6196(11)64003-2","article-title":"The fluoroquinolones","volume":"74","author":"Walker","year":"1999","journal-title":"Mayo Clin Proc"},{"year":"2024","series-title":"Ciprofloxacin","author":"Thai","key":"10.1016\/j.urology.2024.10.071_bib4"},{"key":"10.1016\/j.urology.2024.10.071_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijantimicag.2011.09.004","article-title":"Antimicrobials in urogenital infections","volume":"38","author":"Wagenlehner","year":"2011","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.urology.2024.10.071_bib6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.juro.2008.01.068","article-title":"Best practice policy statement on urologic surgery antimicrobial prophylaxis","volume":"179","author":"Wolf","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2024.10.071_bib7","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1056\/NEJM199102073240606","article-title":"Fluoroquinolone antimicrobial agents","volume":"324","author":"Hooper","year":"1991","journal-title":"New England J Med"},{"key":"10.1016\/j.urology.2024.10.071_bib8","unstructured":"FDA Drug Safety Communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. U.S. Food and Drug Administration. Published July 26, 2016. Accessed May 3, 2024. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics#:\u223c:text=After%20FDA\u2019s%202013%20review%20that,being%20treated%20with%20a%20systemic."},{"key":"10.1016\/j.urology.2024.10.071_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40266-023-01019-3","article-title":"Safety and tolerability of antimicrobial agents in the older patient","volume":"40","author":"Soraci","year":"2023","journal-title":"Drugs Aging"},{"key":"10.1016\/j.urology.2024.10.071_bib10","doi-asserted-by":"crossref","unstructured":"Golomb BA, Koslik HJ, Redd AJ. Fluoroquinolone-induced ser-ious, persistent, multisymptom adverse effects. BMJ Case Rep. 2015; bcr2015209821. https:\/\/doi.org\/10.1136\/bcr-2015-209821","DOI":"10.1136\/bcr-2015-209821"},{"key":"10.1016\/j.urology.2024.10.071_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.931","article-title":"Healthcare costs and mortality associated with serious fluoroquinolone-related adverse reactions","volume":"10","author":"Kuula","year":"2022","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.urology.2024.10.071_bib12","unstructured":"Information for Healthcare Professionals: Fluoroquinolone Antimicrobial Drugs [ciprofloxacin (marketed as Cipro and generic ciprofloxacin), ciprofloxacin extended-release (marketed as Cipro XR and Proquin XR), gemifloxacin (marketed as Factive), levofloxacin (marketed as Levaquin), moxifloxacin (marketed as Avelox), norfloxacin (marketed as Noroxin), and ofloxacin (marketed as Floxin)]. U.S. Food and Drug Administration. Published July 8, 2008. Accessed May 10, 2024. https:\/\/wayback.archive-it.org\/7993\/20161022101528\/http:\/\/www.fda.gov\/Drugs\/DrugSafety\/PostmarketDrugSafetyInformationforPatientsandProviders\/ucm126085.htm."},{"key":"10.1016\/j.urology.2024.10.071_bib13","unstructured":"FDA Drug Safety Communication: FDA requires label changes to warn of risk for possibly permanent nerve damage from antibacterial fluoroquinolone drugs taken by mouth or by injection. U.S Food and Drug Association. Published August 15, 2013. Accessed May 3, 2024. https:\/\/wayback.archive-it.org\/7993\/20161022101530\/http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm365050.htm."},{"key":"10.1016\/j.urology.2024.10.071_bib14","unstructured":"FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. US Food and Drug Administration. Published December 20, 2018. Accessed May 10, 2024. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics."},{"key":"10.1016\/j.urology.2024.10.071_bib15","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1017\/ice.2019.247","article-title":"Impact of FDA black box warning on fluoroquinolone and alternative antibiotic use in southeastern US hospitals","volume":"40","author":"Yarrington","year":"2019","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.urology.2024.10.071_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.36662","article-title":"Association of fluoroquinolone prescribing rates with black box warnings from the US Food and drug administration","volume":"4","author":"Sankar","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.urology.2024.10.071_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.3855\/jidc.17180","article-title":"The use of antibiotic prophylaxis in patients undergoing urologic procedures in an academic hospital Surabaya: a retrospective study","volume":"17","author":"Asmarawati","year":"2023","journal-title":"J Infect Dev Countries"},{"key":"10.1016\/j.urology.2024.10.071_bib18","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/JU.0000000000000509","article-title":"Best practice statement on urologic procedures and antimicrobial prophylaxis","volume":"203","author":"Lightner","year":"2020","journal-title":"J Urology"},{"key":"10.1016\/j.urology.2024.10.071_bib19","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3201\/eid2209.160148","article-title":"Fluoroquinolone-resistant and extended-spectrum \u03b2-lactamase\u2013producing Escherichia coli infections in patients with pyelonephritis, United States1","volume":"22","author":"Talan","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.urology.2024.10.071_bib20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/jac\/dki169","article-title":"Isolation of fluoroquinolone-resistant rectal Escherichia coli after treatment of acute uncomplicated cystitis","volume":"56","author":"Gupta","year":"2005","journal-title":"J Antimicrobial Chemother"},{"key":"10.1016\/j.urology.2024.10.071_bib21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/jac\/49.1.55","article-title":"Molecular epidemiology and evolution of resistance to quinolones in Escherichia coli after prolonged administration of ciprofloxacin in patients with prostatitis","volume":"49","author":"Horcajada","year":"2002","journal-title":"J Antimicrobial Chemother"},{"key":"10.1016\/j.urology.2024.10.071_bib22","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2147\/IDR.S234610","article-title":"Antimicrobial resistance: implications and costs","volume":"12","author":"Dadgostar","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.urology.2024.10.071_bib23","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/bco2.286","article-title":"Fluoroquinolone resistance in urinary tract infections: epidemiology, mechanisms of action and management strategies","volume":"5","author":"Thompson","year":"2024","journal-title":"BJUI Compass"},{"key":"10.1016\/j.urology.2024.10.071_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3390\/microorganisms11040915","article-title":"Presence and relevance of emerging microorganisms in clinical genitourinary samples","volume":"11","author":"Rosales-Castillo","year":"2023","journal-title":"Microorganisms"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524009695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429524009695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:24:19Z","timestamp":1741616659000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429524009695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":24,"alternative-id":["S0090429524009695"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2024.10.071","relation":{},"ISSN":["0090-4295"],"issn-type":[{"type":"print","value":"0090-4295"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analyzing Antibiotic Usage Trends in Genitourinary Infections and Procedures: Insights From the TriNetX Database","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2024.10.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}